Ophthalmologists favor genentech's vabysmo and regeneron's eylea hd for diabetic macular edema treatment despite payer constraints

New prescriptions for vabysmo and eylea hd outpace reported current brand share, indicating further growth of the brands, according to spherix global insights. new prescriptions for vabysmo and eylea hd outpace reported current brand share, indicating further growth of the brands, according to spherix global insights.
REGN Ratings Summary
REGN Quant Ranking